ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 43 filers reported holding ROIVANT SCIENCES LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,449,910 | +16.0% | 7,915,232 | +0.1% | 18.59% | +6.7% |
| Q2 2023 | $79,728,677 | +38.4% | 7,909,591 | +1.3% | 17.43% | -67.0% |
| Q1 2023 | $57,616,450 | +12.5% | 7,807,107 | +21.8% | 52.88% | +8.7% |
| Q4 2022 | $51,219,416 | +171.0% | 6,410,440 | +9.2% | 48.65% | +181.9% |
| Q3 2022 | $18,900,000 | +35.8% | 5,869,690 | +71.6% | 17.26% | -4.7% |
| Q2 2022 | $13,919,000 | +249.2% | 3,419,836 | +323.8% | 18.12% | +442.4% |
| Q1 2022 | $3,986,000 | +27.1% | 806,907 | +159.4% | 3.34% | +38.8% |
| Q4 2021 | $3,135,000 | – | 311,045 | – | 2.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VI Management, LLC | 1,119,489 | $13,075,632 | 99.02% |
| Patient Square Capital LP | 12,639,920 | $147,634,266 | 81.13% |
| QVT Financial LP | 112,541,536 | $1,314,485,140 | 74.33% |
| Two Seas Capital LP | 7,915,232 | $92,449,910 | 18.59% |
| Octagon Capital Advisors LP | 4,367,000 | $51,006,560 | 7.84% |
| SB INVESTMENT ADVISERS (UK) LTD | 73,031,667 | $853,009,871 | 7.02% |
| Decheng Capital Management III (Cayman), LLC | 1,459,700 | $17,049,296 | 5.69% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $56,445,259 | 5.10% |
| Rubric Capital Management LP | 10,500,000 | $122,640,000 | 4.60% |
| Artia Global Partners LP | 914,023 | $10,675,789 | 4.44% |